Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.38B |
| 2 |
Microsoft
MSFT
|
+$2.02B |
| 3 |
Apple
AAPL
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$861M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.67B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.49B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$867M |
| 4 |
Tesla
TSLA
|
+$550M |
| 5 |
GE Aerospace
GE
|
+$483M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Financials | 6.62% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.85% |
| 5 | Communication Services | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Aehr Test Systems
AEHR
$2.27B
| $264K | ﹤0.01% |
7,128
+6,255
| +716% | +$200K |
|
3752
Vitamin Cottage Natural Grocers
NGVC
$744M
| $264K | ﹤0.01% |
10,203
-36,863
| -78% | -$952K |
|
3753
iShares US Oil & Gas Exploration & Production ETF
IEO
$549M
| $264K | ﹤0.01% |
2,110
| – | – |
|
3754
Skyward Specialty Insurance
SKWD
$2.54B
| $263K | ﹤0.01% |
6,018
+1,380
| +30% | +$62.7K |
|
3755
Euroseas
ESEA
$538M
| $262K | ﹤0.01% |
3,919
+1,883
| +92% | +$113K |
|
|
DQ
3756
Daqo New Energy
DQ
$802M
| $261K | ﹤0.01% |
12,252
-81,864
| -87% | -$1.99M |
|
3757
Lexicon Pharmaceuticals
LXRX
$1.04B
| $260K | ﹤0.01% |
166,398
+74,728
| +82% | +$109K |
|
3758
CVR Partners
UAN
$1.29B
| $260K | ﹤0.01% |
2,049
+1,757
| +602% | +$201K |
|
3759
Global E Online
GLBE
$6.53B
| $259K | ﹤0.01% |
8,411
+5,365
| +176% | +$189K |
|
|
ABX
3760
Abacus Global Management
ABX
$1.02B
| $259K | ﹤0.01% |
32,914
+30,861
| +1,503% | +$268K |
|
3761
Ocugen
OCGN
$420M
| $259K | ﹤0.01% |
143,159
+41,281
| +41% | +$71.4K |
|
3762
CorMedix
CRMD
$577M
| $259K | ﹤0.01% |
38,151
-10,694
| -22% | -$79K |
|
3763
Baytex Energy
BTE
$2.86B
| $259K | ﹤0.01% |
+58,108
| New | +$214K |
|
|
HVMCU
3764
Highview Merger Corp Units
HVMCU
| $258K | ﹤0.01% |
25,000
| – | – |
|
|
EONR
3765
EON Resources
EONR
$24M
| $257K | ﹤0.01% |
+309,166
| New | +$183K |
|
|
FAC
3766
Factorial Energy Inc
FAC
$500M
| $256K | ﹤0.01% |
25,000
| – | – |
|
|
MAZE
3767
Maze Therapeutics
MAZE
$1.54B
| $256K | ﹤0.01% |
8,563
-2,689
| -24% | -$119K |
|
3768
MoonLake Immunotherapeutics
MLTX
$1.59B
| $255K | ﹤0.01% |
13,691
+12,781
| +1,405% | +$212K |
|
3769
Taysha Gene Therapies
TSHA
$1.57B
| $255K | ﹤0.01% |
57,080
-5,935
| -9% | -$27.6K |
|
|
PPLT
3770
abrdn Physical Platinum Shares ETF
PPLT
$1.83B
| $255K | ﹤0.01% |
+14,300
| New | +$286K |
|
3771
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $255K | ﹤0.01% |
7,590
+2,198
| +41% | +$74.3K |
|
|
EFC
3772
Ellington Financial
EFC
$1.7B
| $254K | ﹤0.01% |
21,457
-2,417
| -10% | -$30.7K |
|
3773
Adaptive Biotechnologies
ADPT
$3.6B
| $254K | ﹤0.01% |
18,311
-5,697
| -24% | -$90.8K |
|
3774
JPMorgan Diversified Return International Equity ETF
JPIN
$364M
| $254K | ﹤0.01% |
3,566
-270
| -7% | -$19.5K |
|
3775
Ovid Therapeutics
OVID
$440M
| $254K | ﹤0.01% |
114,242
+109,521
| +2,320% | +$196K |
|
Similar funds
Citigroup's Q1 2026 Portfolio in Review
As of Q1 2026, Citigroup held 6,546 positions worth $235B, up 3.5% from $227B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citigroup deployed $16.9B of net new capital in Q1 2026, opening 553 new positions and adding to 2,742 existing holdings. Its largest new stake was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.67B trimmed.
- Citigroup's largest Q1 2026 buy was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
- Citigroup added most to NVIDIA in Q1 2026, an estimated $2.38B increase.
- Citigroup's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.67B.
- Citigroup fully exited CyberArk in Q1 2026, selling an estimated $241M.
- Citigroup's ten largest holdings make up 19% of its $235B portfolio in Q1 2026.
- Citigroup opened 553 new positions and closed 630 in Q1 2026.
- Citigroup's portfolio value rose 3.5% quarter-over-quarter to $235B.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.